CN1204246C - Method for producing indole alkaloid by large-scale culture of complete adaptive cell of catharanthus roseus - Google Patents
Method for producing indole alkaloid by large-scale culture of complete adaptive cell of catharanthus roseus Download PDFInfo
- Publication number
- CN1204246C CN1204246C CN 02136919 CN02136919A CN1204246C CN 1204246 C CN1204246 C CN 1204246C CN 02136919 CN02136919 CN 02136919 CN 02136919 A CN02136919 A CN 02136919A CN 1204246 C CN1204246 C CN 1204246C
- Authority
- CN
- China
- Prior art keywords
- culture
- cell
- substratum
- vinca
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Chemical compound C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 title abstract description 11
- 229930005303 indole alkaloid Natural products 0.000 title abstract description 10
- 240000001829 Catharanthus roseus Species 0.000 title abstract 4
- 230000003044 adaptive effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000012258 culturing Methods 0.000 claims abstract description 15
- 229930013930 alkaloid Natural products 0.000 claims abstract description 10
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 9
- 150000003797 alkaloid derivatives Chemical class 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 8
- 241000863480 Vinca Species 0.000 claims description 25
- 239000001963 growth medium Substances 0.000 claims description 24
- 230000001954 sterilising effect Effects 0.000 claims description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 230000006978 adaptation Effects 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000012010 growth Effects 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 150000002475 indoles Chemical class 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000005556 hormone Substances 0.000 abstract description 11
- 229940088597 hormone Drugs 0.000 abstract description 11
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 abstract description 8
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 abstract description 8
- 238000004113 cell culture Methods 0.000 abstract description 6
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 5
- 229960003048 vinblastine Drugs 0.000 abstract description 5
- 229960004528 vincristine Drugs 0.000 abstract description 5
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 16
- 239000006052 feed supplement Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000024053 secondary metabolic process Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- LPGWZGMPDKDHEP-HLTPFJCJSA-N Leurosine Chemical compound C([C@]1([C@@H]2O1)CC)N(CCC=1C3=CC=CC=C3NC=11)C[C@H]2C[C@]1(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC LPGWZGMPDKDHEP-HLTPFJCJSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001651 autotrophic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- CZJDUZOWQVAEEV-XIEZEKGWSA-N (+)-19-epi-Ajmalicine Natural products O=C(OC)C=1[C@@H]2[C@@H]([C@@H](C)OC=1)C[N+]1[C@H](c3[nH]c4c(c3CC1)cccc4)C2 CZJDUZOWQVAEEV-XIEZEKGWSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 235000004256 Buglossoides arvense Nutrition 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241000118841 Lithospermum incisum Species 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- GRTOGORTSDXSFK-XJTZBENFSA-N ajmalicine Chemical compound C1=CC=C2C(CCN3C[C@@H]4[C@H](C)OC=C([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 GRTOGORTSDXSFK-XJTZBENFSA-N 0.000 description 1
- 229940007897 ajmalicine Drugs 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 230000009876 antimalignant effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- GKWYINOZGDHWRA-UHFFFAOYSA-N catharanthine Natural products C1C(CC)(O)CC(CC2C(=O)OC)CN1CCC1=C2NC2=CC=CC=C12 GKWYINOZGDHWRA-UHFFFAOYSA-N 0.000 description 1
- CMKFQVZJOWHHDV-DYHNYNMBSA-N catharanthine Chemical compound C([C@@H]1C=C([C@@H]2[C@@]3(C1)C(=O)OC)CC)N2CCC1=C3NC2=CC=CC=C12 CMKFQVZJOWHHDV-DYHNYNMBSA-N 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- -1 indoles alkaloid Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ZLQMRLSBXKQKMG-UHFFFAOYSA-N rauniticine Natural products COC(=O)C1=CC2CC3N(CCc4c3[nH]c5ccccc45)CC2C(C)O1 ZLQMRLSBXKQKMG-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention belongs to the field of bioengineering technology. In particular to a novel method for generating indole alkaloid by culturing hormone-completely-adaptive type longshouxin cells. The invention takes the wild catharanthus roseus seeds as the original material to obtain the aseptic seedling of the catharanthus roseus, further induces the callus, establishes a hormone completely adaptive cell culture system suitable for large-scale culture through multi-generation directional induction and domestication, the total alkaloid content in the culture is equivalent to that of the wild catharanthus roseus, but the culture does not contain vinblastine and vincristine with cytotoxicity.
Description
Technical field
The invention belongs to bioengineering field, be specifically related to a kind of Vinca cell large scale and cultivate the method that generates indoles alkaloid.
Background technology
Human utilization to the Secondary Metabolism of Plant material has long history, and is current in the ascendant especially to the research of plant secondary substance.But the output of Secondary Metabolism of Plant material is subjected to the restriction of plant biomass and secondary substance content, and some secondary substance is very little at natural content, thereby has limited to the widespread use of plant secondary substance.Along with in the rapid progress that obtains aspect the biotechnology, people have accumulated in sight and how to utilize biotechnology with in the research that obtains plant secondary substance.Relevant with it for this reason scientists has begun unremitting research and effort, can realize that through the exploration discoveries of the nearly decades large scale culturing by vegetable cell the Secondary Metabolism of Plant material effectively produces.
Large scale culturing production Secondary Metabolism of Plant material by vegetable cell is from extracted form natural plant and artificial bionic is synthetic has its original advantage: (one) does not destroy natural resources; (2) not limited by natural causes such as region season, soil, disease and pest; (3) compare with chemical industry is synthetic, Processes and apparatus is simple, save energy, industrial investment are few, production process does not almost have environmental pollution, to the worker safety height: (four) with from natural plants extract phase ratio, with short production cycle, cell individual difference is little, growth Artificial Control, metabolic process can rationally be adjusted, and helps reducing cost, improving productive rate; (5) can produce the better material of drug effect for some crude substance after modified, also can obtain baroque modifier precursor by this technology; (6) for the active substance that is secreted in the outer nutrient solution of born of the same parents, produce then more convenient.In this regard, study and use many.China Luo Shiwei adopts the fluid suspension culture ginseng-cell, and productive rate can increase day by day one times, and the total content of ginsenoside of culture surpasses the content (9.6%) of cultivated ginseng up to 10.5%, and every cubic metre of nutrient solution can obtain 13.98 kilograms of trepangs.This technology has entered the pilot scale stage at present.Japan uitsui company by paniculatum cell is cultivated produce still can't synthetic Shikonin, the productive rate of culturing cell is 1000 times of n cell productive rates, present Japanese Asian puccoon source mainly is the cell tissue cultivation.Many Secondary Metabolism of Plant products such as trypterygine have all been obtained bigger achievement on producing in addition, and the cultivation scale that has can reach tons up to ten thousand.These experiments and facts have proved, stock plant can produce by the cultivation of vegetable cell by the synthetic secondary metabolites, thereby is considered to a new effective way of utilizing biotechnology to produce secondary metabolites (as medicine, natural pigment, spices, natural condiment containing etc.).
Vinca (Cgtharanthus rosouJ) is an Apocynaceae Vinca plant, and tcm clinical practice has tranquilizing and allaying excitement with all herbal medicine, the effect of flat liver step-down and anti-malignant tumor.So far, in Vinca cell and tissue culture, found more than 60 kind of secondary metabolite altogether, vinealeucoblastine(VLB) (Vinblastine) wherein, vincristine(VCR) (Vincristine), Ah agate's alkali (Ajmalicine), Serpophite (Serpentine) and vincaleucoblastine (Catharanthine) etc. all is important medicine.Vinealeucoblastine(VLB) and vincristine(VCR) have significant curative effect to malignant tumours such as leukemia, have hypoglycemic activity simultaneously: Ah agate's alkali is mainly used in and brings high blood pressure down; Serpophite has antibiotic and antitumor action (effective to mammary cancer), and central nervous system is had persistent stable effect, can be used for treating manic property psychosis.Vincaleucoblastine has antitumor action (ehrlich carcinoma, ascitic type liver cancer and leukemia are had restraining effect), its mechanism of action is similar to colchicine, can make cancer cells mitotic division stop at mid-term, it also has hypoglycemic activity (effect is slow, but effect is lasting).
At present, most of effective constituents all are to produce by extracting from the Vinca plant, and Vinca originates in Madagascar, the marshy terrain, output is limited, mainly cultivates in Hainan Island in China.The method of extract producing biological nicotine from natural phant has its significant disadvantages and limitation: (one) because raw material all comes from agricultural supplies with, thereby in the restriction that is subjected to multiple factors such as season, weather, water and soil, region, upgrowth situation in varying degrees: obtaining of (two) raw material must be to use a large amount of cultivated areas as cost; (3) extraction process complexity: the indole alkaloid in (four) Vinca plant, existing monovalent Ah agate's alkali, Serpophite, vincaleucoblastine etc., vinealeucoblastine(VLB) and vincristine(VCR) that divalence is also arranged, these divalence indole alkaloid have very strong cell toxicant, numerous and diverse their separate process, increased the ratio of input and output more.Break away from dependence if can make the production of unit price indole alkaloid to agriculture production, avoid from natural Vinca, extracting the limitation of this process, the natural product characteristic that keeps simultaneously its product again, take than field planting minimum soil and space, realization is to the industrialized biological production of this Alkaloid intensive style, to promoting of exploitation and the application of this Alkaloid, will be of great immediate significance in fields such as medicine, health cares.
Summary of the invention
Technical problem to be solved by this invention is at the problems referred to above, utilizes the large scale culturing technology of vegetable cell, produces the monocycle indoles alkaloid by the large scale culturing method of the complete adaptation type cell of Vinca.
(1) adaptation type Vinca clone preparation fully
The present invention is achieved by following technical proposals by the method that the complete adaptation type cell cultures of Vinca generates indoles alkaloid:
1. be material with the Vinca seed, the medical ethanol with 70% soaked 30 seconds, was transferred to subsequently and carried out surface sterilization in 10% aqueous sodium hypochlorite solution, was seeded in the B that high-temperature sterilization is crossed
5On the minimum medium, be 25+1 ℃ of following illumination cultivation, get the Vinca aseptic seedling after 10 days in temperature.
2. be explant with organs such as the stem of obtained aseptic seedling, leaves, at B
5The solid-based basal culture medium adds 2, and O.2mg/L 4-D 2mg/L and KT cultivate, and temperature 25+1 ℃, through dark cultivation of 4 weeks, can form callus at the cutting part of explant.
With resulting callus with cultivate on the same medium stable after, average three all subcultures once after 10 generations, form soft, stable callus, culture temperature 25+1 ℃, unglazed photograph.The callus of this moment can be set up suspension cell culture.
4. the callus with above gained continues succeeding transfer culture, in substratum, reduce hormone dosage gradually, cultivate 8-10 after generation, hormone is reduced to zero gradually, as find poor growth, can add 0.1-0.2mg/L 2,4-D, growth is removed hormone again after taking a turn for the better, and simultaneously the medium pH value is reduced to 5.4-5.6; After too much generation domestication, can form the complete adaptation type clone of stable hormone, in solid and liquid B
5All can well grow on the minimum medium, the culture cycle on the solid medium was 4 weeks, and the culture cycle on the liquid nutrient medium is 12-15 days.
(2) growth medium and production medium preparation
Growth medium used in the present invention and production culture medium prescription are as shown in table 1:
Table 1
Growth medium (mg/L) is produced substratum (mg/L)
(NH
4)
2SO
4 134 30
KNO
3 2000 400
CaCl
22H
2O. 150 210
MgSO
47H
2O 250 290
NaH
2PO
4H
2O 150 30
KI 0.75
H
3BO
3 3.0
MnSO
4.4H
2O 10
ZnSO
4.7H
2O 2.0
Na
2MoO
4.2H
2O 0.25
CuSO
4.5H
2O 0.025
CoCl
2.6H
2O 0.025
FeSO
4.7H
2O 27.8 27.8
Na
2.EDTA.2H
2O 37.3 37.3
Inositol 100 100
Nicotinic acid 1.0 0.5
Pyridoxine hydrochloride 1.0 0.5
Vitamin 10 3
Sucrose 2%-3% (w/v) white sugar 3% (w/v)
pH 5.6-5.8
(3) generation of indoles alkaloid
(1) set by step produce culture medium prescription preparation growth medium in (two), be adjusted to pH 5.4-5.6, be sub-packed in (every bottle of 50-60ml) in the 250ml triangular flask, seal and high-temperature sterilization;
(2) be provenance with the cell that makes in the step (), be inoculated in and cultivate amplification in the above-mentioned growth medium that culture condition is 25 ± 1 ℃ of temperature, the dark cultivation, shaking speed 110-120 rev/min, 10 days.
(3) will prepare to such an extent that substratum is sub-packed in 1 liter of culturing bottle in (1), every bottle of 300-400ml, seal and high-temperature sterilization, the culturing cell that makes with (2) is a seed, inoculate, inoculum size is 15% (W/V), continues can extract the acquisition alkaloid after 10-12 days with above-mentioned culture condition cultivation from nutrient solution.
When the final large scale culturing reactor of the present invention surpasses 10 liters, must possess feed supplement irritates, amplification culture needs to increase progressively according to 5-8 times of volume continuously, promptly 10 liters → 50 liters → 250 liters → 1000 liters, as 1000 liters, the need of producing substratum in order to adding are irritated in the feed supplement that be equipped with at least 800 liters at the final step of cultivating.Produce to cultivate generally and only carry out in final one-level of cultivating.
The present invention is a starting materials with the Vinca seed, obtain the aseptic seedling explant of Vinca, explant is carried out inducing culture, set up and filtered out and be fit to the hormone autotrophic type cell by two steps cell culture method production indole alkaloid and set up suspension culture system.Design corresponding growth, produced culture medium prescription.This method has characteristics such as culture cycle is short, productive rate is high, environmentally safe.
The present invention compares than prior art has following advantage:
(1) production process is controlled fully, is not subjected to the influence of physical environment;
(2) no hormone, no agricultural chemicals and heavy-metal residual;
(3) extraction process is simple;
(4) low cost is saved in a large number and is ploughed.
Embodiment
Be described in detail the technical process (being not limited to present embodiment) that the complete adaptation type cell large scale of Vinca of the present invention is cultivated the production indole alkaloid with the embodiment form below:
The culture plant cell reactor that embodiment is 1 10 liters is cultivated the method for the complete adaptation type cells produce of Vinca hormone unit price indole alkaloid
1. the preparation of triangular flask cell seed on the shaking table
(1) forms (seeing Table 1) by grown cultures based formulas of the present invention, the preparation growth medium.Measure the pH value with pH meter, and regulate the medium pH value in the 5.4-5.6 scope with the HCl of 1N and the NaOH of 1N.Be sub-packed in the triangular flask of 250ml every bottle of 50-60ml then.After sealing with cotton and paper, carry out autoclaving, pressure is 1.0-1.2Kg/cm
2, the time is 15-25 minute.
(2) be provenance with the complete adaptation type cell of Vinca hormone, in Bechtop, be inoculated in the above ready liquid growth medium and cultivate amplification that inoculum size (in the cell fresh weight) is 6%-8% (w/v).Postvaccinal culturing bottle is put on the shaking table of culturing room, and culture condition is: 25 ± 1 ℃ of temperature, and dark the cultivation, shaking speed 110-120 rev/min, but subculture is once after 10 days.
(3) growth medium for preparing is sub-packed in 1 liter culturing bottle, every bottle of 300-400ml.After sealing with cotton and paper, carry out autoclaving, pressure is 1.0-1.2Kg/cm
2, the time is 15-25 minute.
(4) be seed with 250mL shake-flask culture cell, be inoculated in youngster and shake in the bottle that inoculum size is 8% (w/v), culture condition is with (2).Cultivate and to insert in 10 liters of reactors after 10-12 days.
2.10 rising reactor cultivates
Dispose 10 liters of production substratum, place reactor, by specification requires autosterilization on the throne, after sterilization finishes, regulates the tank body air outlet valve, to guarantee the gas malleation in jar and the pipeline.Insert the cell of logarithmic phase in inoculation tank, inoculum size is 15% (W/V), cultivates 25 ± 1 ℃ of temperature, Ventilation Rate 0.5vvm, 100 rev/mins of stirring velocitys (helical runner).Dark.Cultivated 10-12 days, when PCV reaches more than 75%, the cell growth reaches index latter stage, takes a sample when Ah agate's alkali content reaches 3.5mg/L, extracts alkaloid.
Complete two steps of adaptation type cell of 2 70 liters of culture plant cell reactors of embodiment Vinca hormone are cultivated the method for production indole alkaloid
1. the same example of preparation of triangular flask cell seed on the shaking table.
2.70 rise the preparation of reactor assembly sterilization and substratum
(1) pipeline and the air filter of cultivating reactor carried out steam sterilizing: sterilisation vapour pressure is 1.2-1.4Kg/cm
2, time 20-30 minute.Steam sterilizing finishes, and uses 1.5-2.0Kg/cm immediately
2The air blow drying pipeline and the water of condensation in the air filter, need 20-30 minute usually, the terminal valve of blinding off a line is to guarantee the gas malleation in the pipeline.
(2) sky disappears: culture tank and the feed supplement jar of cultivating reactor carried out steam sterilizing, and sterilisation vapour pressure is 1.2-1.4Kg/cm
2, time 30-40 minute.Steam sterilizing finishes, and treats that tank body pressure reduces to 0.5Kg/cm
2The time open the intake valve of culture tank and feed supplement jar, regulate the tank body air outlet valve, to guarantee that gaseous tension maintains 0.3-0.5Kg/cm in the tank body
2Scope in.
(3) real disappearing: after the temperature for the treatment of culture tank and feed supplement jar is reduced to below 70 ℃, close the tank body air outlet valve, open the charging opening of culture tank and feed supplement jar, in culture tank, add growth medium mother liquor and distilled water to the 25-30 liter, in the feed supplement jar, add production substratum (seeing Table 1) mother liquor and distilled water to the 45-50 liter, regulate the medium pH value in the 5.0-6.0 scope, close the charging opening and the intake valve of culture tank and feed supplement jar.Pass to 0.2Kg/cm
2Water vapour, treat that tank body pressure rises to 0.5Kg/cm
2The time open the air outlet valve of culture tank and feed supplement jar, exitted crack subsequently the two air outlet valve 5-10 minute.Treat that a jar internal pressure rises to 1.2-1.3Kg/cm
2The time, the air outlet valve of regulating water vapour intake valve and culture tank and feed supplement jar is to guarantee that vapor pressure maintains 1.2-1.3Kg/cm in the tank body
2Scope in, carry out that high temperature is real to disappear.Close the water vapour intake valve after 25-30 minute, open water of condensation manual valve cooling tank body, treat that tank body pressure reduces to 0.5Kg/cm
2The time open the air outlet valve of culture tank and feed supplement jar, regulate the tank body air outlet valve, to guarantee that gaseous tension maintains 0.3-0.5Kg/cm in the tank body
2Scope in.
(4) inoculation: the culture tank tank deck rear (the inoculation mouth is positioned at tank deck) that aseptic level air-supply platform is installed on cell culture reactor, aseptic level air-supply is after 20-30 minute, close the culture tank air outlet valve, the culture tank intake valve open is extremely maximum, light inoculation mouthful pyrosphere, open the inoculation flap, with the ready triangular flask bottleneck flame sterilization that fills the cell provenance, pour into the cell provenance in the culture tank fast by the inoculation mouth of the pyrosphere that burning afterwards, cover inoculation flap and screwing rapidly, regulate culture tank intake valve and air outlet valve at last, guarantee that gaseous tension maintains 0.3-0.5Kg/cm in the tank body
2Scope in.
(5) grown cultures and monitoring: by culture condition of the present invention, 25 ± 1 ℃ of temperature, unglazed photograph, system's control automatically cultivates, and grown cultures 10 days reaches biomass index latter stage, and the sampling monitoring pcv value reaches promptly to be finished one step growth and cultivates more than 75%.
(6) produce cultivation and monitoring: drain growth medium with the marker pipe that has the cell filtration device, subsequently with the bacterium of having gone out in the feed supplement jar the production substratum mend in the cell culture reactor through aseptic pipeline pressure reduction, produce cultivation, by culture condition of the present invention, 28 ± 1 ℃ of temperature, unglazed photograph, system's control automatically cultivates, produce and cultivated 10-12 days, sampling monitoring culture Ah agate alkali content reaches can finish the production cultivation of two steps more than the 3.5mg/L.
(7) culture is discharged with the marker pipe that does not have the cell filtration device, carry out alkaloid extraction.
Embodiment 3
In the laboratory lab scale is cultivated, form by grown cultures based formulas of the present invention, the preparation growth medium, sucrose concentration 20g/L regulates the medium pH value 5.6.Be sub-packed in the triangular flask of 250ml every bottle of 50-70ml then.After sealing with cotton and paper, carry out autoclave sterilization, pressure is 1.0-1.2Kg/cm
2, the time is 15-25 minute.With Vinca hormone autotrophic type cell is provenance, is inoculated in above being ready to and cultivates in the liquid growth medium in Bechtop, and inoculum size is 5%-10% (w/v).Postvaccinal culturing bottle is put on the shaking table of culturing room, culture condition is: 25 ± 1 ℃ of temperature, unglazed photograph, 120 rev/mins of shaking speed, cultivate that every bottle of cell fresh weight can reach 35g after 10 days, it is gone to (the same growth medium of process for preparation) in the production substratum of the present invention, culture condition, 25 ± 1 ℃ of temperature, unglazed photograph cultivates that every bottle of cell fresh weight can reach (the P/V value reaches 85%) about 50g after 8-10 days, and the culture total alkaloid content reaches 0.48%, be more or less the same with total alkaloid content in the plant, do not have cytotoxic divalence indole alkaloid but do not contain in this culture.
Claims (1)
1. use the method that the Vinca cell large scale is cultivated the generation indoles alkaloid for one kind, it is characterized in that this method comprises the following steps:
(1) by formulated growth and production substratum:
Growth medium mg/L produces substratum mg/L
(NH
4)
2SO
4 134 30
KNO
3 2000 400
CaCl
22H
2O. 150 210
MgSO
47H
2O 250 290
NaH
2PO
4H
2O 150 30
KI 0.75
H
3BO
3 3.0
MnSO
4·4H
2O 10
ZnSO
4·7H
2O 2.0
Na
2MoO
4·2H
2O 0.25
CuSO
4·5H
2O 0.025
CoCl
2·6H
2O 0.025
FeSO
4·7H
2O 27.8 27.8
Na
2·EDTA·2H
2O 37.3 37.3
Inositol 100 100
Nicotinic acid 1.0 0.5
Pyridoxine hydrochloride 1.0 0.5
Vitamin 10 3
Sucrose 2%-3%w/v white sugar 3%w/v
pH 5.6-5.8
(2) adaptation type Vinca clone preparation fully
1) is material with the Vinca seed, obtains aseptic seedling through sterilization and cultivation;
2) be explant with organs such as the stem of obtained aseptic seedling, leaves, at B
5The solid-based basal culture medium adds 2, and O.2mg/L 4-D 2mg/L and KT cultivate, temperature 25+1 ℃, through dark cultivation of 4 weeks, at the cutting part formation callus of explant;
3) with resulting callus with above-mentioned 2) identical 10 generations of culture medium culturing, average three all subcultures once, culture temperature 25+1 ℃, unglazed photograph;
4) callus of gained is continued succeeding transfer culture, above-mentioned 2) reduce 2 gradually in the described substratum, the 4-D consumption is cultivated 8-10 after generation, and with 2,4-D reduces to zero, solid B
5Culture cycle on the substratum was 4 weeks, or liquid B
5Culture cycle on the substratum is 12-15 days, forms stable complete adaptation type Vinca clone;
(3) press growth medium formulation growth medium, be adjusted to pH5.4-5.6, be sub-packed in the 250ml triangular flask, seal and high-temperature sterilization, the cell that makes with step (2) method is a provenance, be inoculated in and cultivate amplification in the above-mentioned growth medium, culture condition is 25 ± 1 ℃ of temperature, dark cultivation, shaking speed 110-120 rev/min, 10 days subcultures once, as seed cell;
(4) produce substratum by producing the culture medium prescription preparation, be adjusted to pH5.4-5.6, be sub-packed in the 1000ml triangular flask every bottle of 300-400ml, insert seed cell by 15%W/V and cultivate, 25 ± 1 ℃ of temperature, shaking speed are 120 rev/mins, dark was cultivated after 10-12 days, extracted alkaloid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02136919 CN1204246C (en) | 2002-09-10 | 2002-09-10 | Method for producing indole alkaloid by large-scale culture of complete adaptive cell of catharanthus roseus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02136919 CN1204246C (en) | 2002-09-10 | 2002-09-10 | Method for producing indole alkaloid by large-scale culture of complete adaptive cell of catharanthus roseus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1401781A CN1401781A (en) | 2003-03-12 |
CN1204246C true CN1204246C (en) | 2005-06-01 |
Family
ID=4748819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02136919 Expired - Fee Related CN1204246C (en) | 2002-09-10 | 2002-09-10 | Method for producing indole alkaloid by large-scale culture of complete adaptive cell of catharanthus roseus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1204246C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11299700B1 (en) | 2021-02-19 | 2022-04-12 | Acequia Biotechnology, Llc | Bioreactor containers and methods of growing hairy roots using the same |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100357296C (en) * | 2005-04-27 | 2007-12-26 | 东北林业大学 | Method for processing production raw materials of vinca alkaloid |
CN100340163C (en) * | 2005-12-08 | 2007-10-03 | 上海交通大学 | Plant regeneration method of vinca from hairly root |
CN100429215C (en) * | 2005-12-19 | 2008-10-29 | 东北林业大学 | Method for increasing vinblastine content in catharanthus roseus |
CN101168732B (en) * | 2007-08-24 | 2010-06-02 | 清华大学 | Method for producing Vinca rosea alkaloid |
CN102613088A (en) * | 2012-04-23 | 2012-08-01 | 上海安体康生植物化学有限公司 | Fast propagation method for cultivating salt-tolerant and low temperature-tolerant periwinkle strain |
CN106754628A (en) * | 2016-11-15 | 2017-05-31 | 天津市博爱生物药业有限公司 | A kind of synthetic media for inducing Catharanthus Roseus Cell to secrete catharanthine |
CN109122323A (en) * | 2018-10-22 | 2019-01-04 | 覃家日 | The cultural method of Catharanthus Roseus Cell high yield vincaleukoblastinum |
-
2002
- 2002-09-10 CN CN 02136919 patent/CN1204246C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11299700B1 (en) | 2021-02-19 | 2022-04-12 | Acequia Biotechnology, Llc | Bioreactor containers and methods of growing hairy roots using the same |
Also Published As
Publication number | Publication date |
---|---|
CN1401781A (en) | 2003-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102138436A (en) | Method for culturing selenium-enriched Cordyceps militaris | |
CN103563655B (en) | Cultivate the technique of live body nymphosis CORDYCEPS | |
CN109429894A (en) | The selenium-enriched cordceps militaris and its cultural method of a kind of high adenosine content and application | |
CN102428834A (en) | Cultivation method of selenium-enriched Cordyceps militaris mother culture | |
CN102771314A (en) | Method for culturing selenium-enriched cordyceps militaris | |
CN106495810A (en) | A kind of Armillaria mellea culture base material for gastrodin cultivation and preparation method thereof | |
CN100374546C (en) | Industrial preparing process, fermented liquid and use of spheroidal erythrocyte | |
CN117025400B (en) | Chlorella pyrenoidosa for producing nano-selenium, application thereof and nano-selenium preparation method | |
CN1204246C (en) | Method for producing indole alkaloid by large-scale culture of complete adaptive cell of catharanthus roseus | |
CN102552335A (en) | Traditional Chinese medicine health care product, its preparation method and its application | |
WO2019062354A1 (en) | Fungal elicitor, preparation method therefor, and method for rapid propagation of bletilla striata seedlings using fungal elicitor | |
CN102329826A (en) | Method for producing grease rich in essential fatty acid linoleic acid and alpha-linolenic acid through culturing microalgae by use of CO2 | |
CN108034681B (en) | Method for producing catalpol by using suspension culture rehmannia stem cambium stem cells | |
CN103421695A (en) | Symbiotic fungus and application thereof in tissue culture and cultivation phase of Dendrobium officinale | |
CN101358180B (en) | Method for producing triptolide and alkaloids by tripterygium wilfordii cell culture method | |
CN1186443C (en) | Snow lotus cell series with stable high productive flavone for mass plant cell culture and its establishing method | |
CN114836324B (en) | Haematococcus pluvialis high-temperature-resistant mutant strain and application thereof | |
CN112154919B (en) | Culture medium and method for inducing calli of paris polyphylla to directly grow seedlings | |
CN101619326B (en) | Method for preparing flavonoid compound by guava cell culture method | |
US20220167577A1 (en) | Method of production of phytocannabinoids for use in medical treatments | |
CN1212387C (en) | Fine rod bundle spore SX-1 separated and cultured from cordyceps and its saparation, culture process and use | |
CN112042533A (en) | Universal culture medium for cultivating and seedling growing of rhizome tissue and preparation method thereof | |
CN111690706A (en) | Method for producing gibberellin A by fermentation of riboflavin waste liquid3Method (2) | |
CN104450817A (en) | Method for producing flavone of anoectochilus roxburghii by suspension cultivation of cells | |
CN110972806A (en) | Cultivation method and artificial cultivation method of sulphur vermilion strain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050601 Termination date: 20160910 |
|
CF01 | Termination of patent right due to non-payment of annual fee |